These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11294633)

  • 1. DNA interaction of the tyrosine protein kinase inhibitor PD153035 and its N-methyl analogue.
    Goossens JF; Bouey-Bencteux E; Houssin R; Hénichart JP; Colson P; Houssier C; Laine W; Baldeyrou B; Bailly C
    Biochemistry; 2001 Apr; 40(15):4663-71. PubMed ID: 11294633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA-binding epidermal growth factor-receptor inhibitor PD153035 and other DNA-intercalating cytotoxic drugs reactivate the expression of the retinoic acid receptor-beta tumor-suppressor gene in breast cancer cells.
    Grunt TW; Tomek K; Wagner R; Puckmair K; Zielinski CC
    Differentiation; 2007 Nov; 75(9):883-90. PubMed ID: 17608728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells.
    Bonjean K; De Pauw-Gillet MC; Defresne MP; Colson P; Houssier C; Dassonneville L; Bailly C; Greimers R; Wright C; Quetin-Leclercq J; Tits M; Angenot L
    Biochemistry; 1998 Apr; 37(15):5136-46. PubMed ID: 9548744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin.
    Bailly C; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M; Waring MJ
    Mol Pharmacol; 1998 Jan; 53(1):77-87. PubMed ID: 9443934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants for DNA minor groove recognition: design of a bis-guanidinium derivative of ethidium that is highly selective for AT-rich DNA sequences.
    Bailly C; Arafa RK; Tanious FA; Laine W; Tardy C; Lansiaux A; Colson P; Boykin DW; Wilson WD
    Biochemistry; 2005 Feb; 44(6):1941-52. PubMed ID: 15697219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of retinoic acid receptor-beta by the epidermal growth factor-receptor inhibitor PD153035 is not mediated by blockade of ErbB pathways.
    Grunt TW; Tomek K; Wagner R; Puckmair K; Kainz B; Rünzler D; Gaiger A; Köhler G; Zielinski CC
    J Cell Physiol; 2007 Jun; 211(3):803-15. PubMed ID: 17286282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives.
    Bailly C; Dassonneville L; Carrasco C; Lucas D; Kumar A; Boykin DW; Wilson WD
    Anticancer Drug Des; 1999 Feb; 14(1):47-60. PubMed ID: 10363027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the binding mode and binding affinity constant of tyrosine kinase inhibitor PD153035 to DNA using optical tweezers.
    Cheng CM; Lee YJ; Wang WT; Hsu CT; Tsai JS; Wu CM; Ou KL; Yang TS
    Biochem Biophys Res Commun; 2011 Jan; 404(1):297-301. PubMed ID: 21130075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
    Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
    Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
    Bailly C; Hénichart JP; Colson P; Houssier C
    J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting DNA with novel diphenylcarbazoles.
    Dias N; Jacquemard U; Baldeyrou B; Tardy C; Lansiaux A; Colson P; Tanious F; Wilson WD; Routier S; Mérour JY; Bailly C
    Biochemistry; 2004 Dec; 43(48):15169-78. PubMed ID: 15568808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence specificity of the binding of 9-aminoacridine- and amsacrine-4-carboxamides to DNA studied by DNase I footprinting.
    Bailly C; Denny WA; Mellor LE; Wakelin LP; Waring MJ
    Biochemistry; 1992 Apr; 31(13):3514-24. PubMed ID: 1554731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and biophysical properties of positively supercoiled DNA.
    Liu Y; Berrido AM; Hua ZC; Tse-Dinh YC; Leng F
    Biophys Chem; 2017 Nov; 230():68-73. PubMed ID: 28887044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berenil [1,3-bis(4'-amidinophenyl)triazene] binding to DNA duplexes and to a RNA duplex: evidence for both intercalative and minor groove binding properties.
    Pilch DS; Kirolos MA; Liu X; Plum GE; Breslauer KJ
    Biochemistry; 1995 Aug; 34(31):9962-76. PubMed ID: 7632695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel dications with unfused aromatic systems: trithiophene and trifuran derivatives of furimidazoline.
    Bilik P; Tanious F; Kumar A; Wilson WD; Boykin DW; Colson P; Houssier C; Facompré M; Tardy C; Bailly C
    Chembiochem; 2001 Aug; 2(7-8):559-69. PubMed ID: 11828489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromophore-modified bisnaphthalimides: DNA recognition, topoisomerase inhibition, and cytotoxic properties of two mono- and bisfuronaphthalimides.
    Bailly C; Carrasco C; Joubert A; Bal C; Wattez N; Hildebrand MP; Lansiaux A; Colson P; Houssier C; Cacho M; Ramos A; Braña MF
    Biochemistry; 2003 Apr; 42(14):4136-50. PubMed ID: 12680768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.
    Bos M; Mendelsohn J; Kim YM; Albanell J; Fry DW; Baselga J
    Clin Cancer Res; 1997 Nov; 3(11):2099-106. PubMed ID: 9815602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer.
    Fozing T; Scheuer C; Samnick S
    Eur J Med Chem; 2010 Sep; 45(9):3780-6. PubMed ID: 20538380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential intercalation at AT sequences in DNA by lucanthone, hycanthone, and indazole analogs. A footprinting study.
    Bailly C; Waring MJ
    Biochemistry; 1993 Jun; 32(23):5985-93. PubMed ID: 8389585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.